Hadassah BrainLabs is a renowned research institution based in Israel that is actively involved in studying the potential therapeutic applications of psychedelics. Led by a team of dedicated scientists and researchers, Hadassah BrainLabs aims to explore the effects of psychedelic substances on various neurological and psychiatric disorders.
Research Focus:
- Psychedelic-Assisted Therapy: Hadassah BrainLabs is investigating the use of psychedelics, such as psilocybin and MDMA, in combination with psychotherapy to treat conditions like post-traumatic stress disorder (PTSD), depression, anxiety, and addiction.
- Neuroplasticity and Brain Imaging: The research team at Hadassah BrainLabs is studying the impact of psychedelics on neuroplasticity, which refers to the brain’s ability to reorganize and form new connections. They utilize advanced brain imaging techniques to understand the neural mechanisms underlying the therapeutic effects of psychedelics.
- Safety and Efficacy: Hadassah BrainLabs is committed to conducting rigorous clinical trials to assess the safety and efficacy of psychedelic substances. Their research aims to provide evidence-based insights into the potential benefits and risks associated with psychedelic-assisted therapies.
Explore more company info with a Tree membership
📰 Weekly newsletter about the business of psychedelics
📈 Extended company information (analyst view, fundraising, revenue numbers)
🪄 Priority company page updates